FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Sodium Phosphate, Dibasic, Anhydrous, Sodium Phosphate, Monobasic, Monohydrate Injection
Status: Currently in Shortage
»Date first posted: 09/01/2021
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition

Expand all

Fresenius Kabi USA, LLC (Revised 05/08/2024)

Company Contact Information:
888-386-1300

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Sodium Phosphates, Injection, 142 mg/1 mL; 276 mg/1 mL (NDC 63323-884-06)	Unavailable	Backordered. Next release May 2024.	Demand increase for the drug
Sodium Phosphates, Injection, 142 mg/1 mL; 276 mg/1 mL (NDC 63323-881-16)	Unavailable	Check wholesaler for inventory; Backordered. Next release May 2024.	Demand increase for the drug
Sodium Phosphates, Injection, 142 mg/1 mL; 276 mg/1 mL (NDC 63323-886-56)	Unavailable	Check wholesaler for inventory; Backordered. Next release May 2024.	Demand increase for the drug

Hospira, Inc., a Pfizer Company (Revised 05/15/2024)

Company Contact Information:
844-646-4398

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Sodium Phosphates In Plastic Container, Injection, Phosphorus 45 mmol/15 mL, Sodium 60 mEq/15 mL (NDC 0409-7391-72)	Limited Availability	Limited Supply Available. Next Delivery: May 2024; Estimated Recovery: June 2024; Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay	Delay in shipping of the drug